Brussels, 02/09/2002 (Agence Europe) - The European Commission has relaunched discussion over the transparency of medicine pricing, in line with the G10 recommendations for criteria for accessing Member States' markets and has convened a meeting of the Transparency Committee set up under a 1988 directive on the transparency of human medicines pricing and their inclusion in the scope of national sickness insurance schemes. The Committee, made up of Member States' representatives, monitors the...